UCB | Tillgångar



Assets Ändra Datum
Alcon AG USD 30.35B 15M 2024-12
Almirall EUR 2.32B 14.19M 2024-06
Amarin USD 750.62M 49.24M 2024-09
AstraZeneca USD 104.04B 887M 2024-12
Bayer EUR 110.85B 3.9B 2024-12
Galapagos EUR 4.14B 36.48M 2024-12
Genmab DKK 45.81B 6.15B 2024-12
GlaxoSmithKline GBP 59.46B 1.41B 2024-12
GRIFOLS EUR 21.41B 1.12B 2024-12
Hikma Pharmaceutical USD 4.85B 167M 2024-06
Lonza CHF 19.73B 1.85B 2024-12
Merck EUR 51.57B 1.42B 2024-12
Novartis USD 102.25B 1.28B 2024-12
Orion EUR 1.63B 21.4M 2024-12
Recordati EUR 4.2B 2.87M 2024-09
Roche Holding CHF 101.8B 6.02B 2024-12
Sanofi 129.76B 3.29B 2024-06
UCB EUR 17.35B 1.72B 2024-12
Unibail Rodamco EUR 53.55B 298.5M 2024-12



UCB Tillgångar - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.